| 1 |
Imataki H, Miyake H, Nagai H, Yoshioka Y, Yuasa N, Takamizawa J, Kiriyama A, Fujino M. Diagnosis and clinical implication of collision gastric adenocarcinomas: a case report. Surg Case Rep 2022;8:193. [PMID: 36207547 DOI: 10.1186/s40792-022-01543-1] [Reference Citation Analysis]
|
| 2 |
Ju MK, Lee JR, Choi Y, Park SY, Sul HJ, Chung HJ, An S, Lee S, Jung E, Kim B, Choi BY, Kim BJ, Kim HS, Lim H, Kang HS, Soh JS, Myung K, Kim KC, Cho JW, Seo J, Kim TM, Lee JY, Kim Y, Kim H, Zang DY. PWWP2B promotes DNA end resection and homologous recombination. EMBO Reports 2022;23. [DOI: 10.15252/embr.202153492] [Reference Citation Analysis]
|
| 3 |
Kole C, Charalampakis N, Tsakatikas S, Kouris NI, Papaxoinis G, Karamouzis MV, Koumarianou A, Schizas D. Immunotherapy for gastric cancer: a 2021 update. Immunotherapy 2021. [PMID: 34784774 DOI: 10.2217/imt-2021-0103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 4 |
Nshizirungu JP, Bennis S, Mellouki I, Benajah DA, Lahmidani N, El Bouhaddoutti H, Ibn Majdoub K, Ibrahimi SA, Pires Celeiro S, Viana-Pereira M, Manuel Reis R. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients. Genet Test Mol Biomarkers 2021;25:116-23. [PMID: 33596142 DOI: 10.1089/gtmb.2020.0146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Huo X, Xiao X, Zhang S, Du X, Li C, Bai Z, Chen Z. Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor-related genes in gastric cancer. Oncol Lett 2021;21:430. [PMID: 33868468 DOI: 10.3892/ol.2021.12691] [Reference Citation Analysis]
|
| 6 |
Zepeda-Najar C, Palacios-Astudillo RX, Chávez-Hernández JD, Lino-Silva LS, Salcedo-Hernández RA. Prognostic impact of microsatellite instability in gastric cancer. Contemp Oncol (Pozn) 2021;25:68-71. [PMID: 33911985 DOI: 10.5114/wo.2021.104939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Salari S, Ghadyani M, Karimi M, Mortezazadeh M, Vahedifard F. Immunohistochemical Expression Pattern of MLH1, MSH2, MSH6, and PMS2 in Tumor Specimen of Iranian Gastric Carcinoma Patients. J Gastrointest Cancer 2021. [PMID: 33411254 DOI: 10.1007/s12029-020-00566-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. Int J Mol Sci 2020;21:E9400. [PMID: 33321820 DOI: 10.3390/ijms21249400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 9 |
De Souza ALPB. Finding the hot spot: identifying immune sensitive gastrointestinal tumors. Transl Gastroenterol Hepatol 2020;5:48. [PMID: 33073043 DOI: 10.21037/tgh.2019.12.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Cai L, Sun Y, Wang K, Guan W, Yue J, Li J, Wang R, Wang L. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer. Front Oncol 2020;10:1269. [PMID: 32850385 DOI: 10.3389/fonc.2020.01269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 11 |
Auslander N, Wolf YI, Koonin EV. Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability. Nat Commun 2020;11:1234. [PMID: 32144251 DOI: 10.1038/s41467-020-15094-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 12 |
Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
|
| 13 |
Afshari F, Soleyman-Jahi S, Keshavarz-Fathi M, Roviello G, Rezaei N. The promising role of monoclonal antibodies for gastric cancer treatment. Immunotherapy 2019;11:347-64. [PMID: 30678552 DOI: 10.2217/imt-2018-0093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 14 |
Rotin DL, Paklina OV, Tin’kova IO, Grekov DN. MICROSATELLITE INSTABILITY AND GASTRIC CARCINOMA. REVIEW OF THELITERATURE. Rossijskij bioterapevtičeskij žurnal 2019;18:17-24. [DOI: 10.17650/1726-9784-2019-18-4-17-24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Verma R, Agarwal AK, Sakhuja P, Sharma PC. Microsatellite instability in mismatch repair and tumor suppressor genes and their expression profiling provide important targets for the development of biomarkers in gastric cancer. Gene 2019;710:48-58. [DOI: 10.1016/j.gene.2019.05.051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 16 |
Martinez-Ciarpaglini C, Fleitas-Kanonnikoff T, Gambardella V, Llorca M, Mongort C, Mengual R, Nieto G, Navarro L, Huerta M, Rosello S, Roda D, Tarazona N, Navarro S, Ribas G, Cervantes A. Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications. ESMO Open 2019;4:e000470. [PMID: 31231566 DOI: 10.1136/esmoopen-2018-000470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 17 |
Paul P, Malakar AK, Chakraborty S. The significance of gene mutations across eight major cancer types. Mutat Res Rev Mutat Res 2019;781:88-99. [PMID: 31416581 DOI: 10.1016/j.mrrev.2019.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 18 |
Xing R, Zhou Y, Yu J, Yu Y, Nie Y, Luo W, Yang C, Xiong T, Wu WKK, Li Z, Bing Y, Lin S, Zhang Y, Hu Y, Li L, Han L, Yang C, Huang S, Huang S, Zhou R, Li J, Wu K, Fan D, Tang G, Dou J, Zhu Z, Ji J, Fang X, Lu Y. Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer. Nat Commun 2019;10:2037. [PMID: 31048690 DOI: 10.1038/s41467-019-09644-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 19 |
Gorlov I, Orlow I, Ringelberg C, Hernando E, Ernstoff MS, Cheng C, Her S, Parker JS, Thompson CL, Gerstenblith MR, Berwick M, Amos C. Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Res 2018;28:380-9. [PMID: 29975213 DOI: 10.1097/CMR.0000000000000473] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 20 |
Haron NH, Mohamad Hanif EA, Abdul Manaf MR, Yaakub JA, Harun R, Mohamed R, Mohamed Rose I. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer. Asian Pac J Cancer Prev 2019;20:509-17. [PMID: 30803214 DOI: 10.31557/APJCP.2019.20.2.509] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 21 |
Fountzilas C, Lee SS, Iyer RV, Boland PM. Immune Checkpoint Inhibitors in Gastrointestinal Malignancies. Immune Checkpoint Inhibitors in Cancer 2019. [DOI: 10.1016/b978-0-323-54948-6.00004-4] [Reference Citation Analysis]
|
| 22 |
Vrána D, Matzenauer M, Neoral Č, Aujeský R, Vrba R, Melichar B, Rušarová N, Bartoušková M, Jankowski J. From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer. Int J Mol Sci 2018;20:E13. [PMID: 30577521 DOI: 10.3390/ijms20010013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 23 |
Ratti M, Lampis A, Hahne JC, Passalacqua R, Valeri N. Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cell Mol Life Sci. 2018;75:4151-4162. [PMID: 30173350 DOI: 10.1007/s00018-018-2906-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 24 |
Mizuguchi A, Takai A, Shimizu T, Matsumoto T, Kumagai K, Miyamoto S, Seno H, Marusawa H. Genetic features of multicentric/multifocal intramucosal gastric carcinoma. Int J Cancer 2018;143:1923-34. [DOI: 10.1002/ijc.31578] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 25 |
Chivu-Economescu M, Matei L, Necula LG, Dragu DL, Bleotu C, Diaconu CC. New therapeutic options opened by the molecular classification of gastric cancer. World J Gastroenterol 2018; 24(18): 1942-1961 [PMID: 29760539 DOI: 10.3748/wjg.v24.i18.1942] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 26 |
Hang X, Li D, Wang J, Wang G. Prognostic significance of microsatellite instabilityassociated pathways and genes in gastric cancer. Int J Mol Med. 2018;42:149-160. [PMID: 29717769 DOI: 10.3892/ijmm.2018.3643] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 27 |
Jin S, Xu B, Yu L, Fu Y, Wu H, Fan X, Wei J, Liu B. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy. Oncotarget. 2017;8:38850-38862. [PMID: 28418918 DOI: 10.18632/oncotarget.16407] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 28 |
Ammannagari N, Atasoy A. Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers. J Gastrointest Oncol 2018;9:196-207. [PMID: 29564185 DOI: 10.21037/jgo.2017.06.12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 29 |
Yuza K, Nagahashi M, Watanabe S, Takabe K, Wakai T. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017;8:112103-15. [PMID: 29340115 DOI: 10.18632/oncotarget.22783] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 30 |
Polom K, Marano L, Marrelli D, De Luca R, Roviello G, Savelli V, Tan P, Roviello F. Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.Br J Surg. 2018;105:159-167. [PMID: 29091259 DOI: 10.1002/bjs.10663] [Cited by in Crossref: 114] [Cited by in F6Publishing: 131] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 31 |
Mathiak M, Warneke VS, Behrens HM, Haag J, Böger C, Krüger S, Röcken C. Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.Appl Immunohistochem Mol Morphol. 2017;25:12-24. [PMID: 26371427 DOI: 10.1097/PAI.0000000000000264] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 32 |
Kim JG, Shin S, Park J. Comparison between mononucleotide and dinucleotide marker panels in gastric cancer with loss of hMLH1 or hMSH2 expression. Int J Biol Markers 2017;32:e352-6. [PMID: 28525661 DOI: 10.5301/ijbm.5000266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 33 |
Kim JW, Lee HS, Nam KH, Ahn S, Kim JW, Ahn SH, Park DJ, Kim HH, Lee KW. PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer. Oncotarget. 2017;8:90948-90958. [PMID: 29207615 DOI: 10.18632/oncotarget.18770] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 34 |
Figueiredo C, Camargo MC, Leite M, Fuentes-Pananá EM, Rabkin CS, Machado JC. Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Curr Top Microbiol Immunol 2017;400:277-304. [PMID: 28124158 DOI: 10.1007/978-3-319-50520-6_12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Shen H, Zhong M, Wang W, Liao P, Yin X, Rotroff D, Knepper TC, Mcleod HL, Zhou C, Xie S, Li W, Xu B, He Y. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients. Clin Chim Acta 2017;471:216-21. [PMID: 28601671 DOI: 10.1016/j.cca.2017.06.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 36 |
Park J, Yoo HM, Jang W, Shin S, Kim M, Kim Y, Lee SW, Kim JG. Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer. Medicine (Baltimore) 2017;96:e7224. [PMID: 28640116 DOI: 10.1097/MD.0000000000007224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 37 |
Schumacher SE, Shim BY, Corso G, Ryu MH, Kang YK, Roviello F, Saksena G, Peng S, Shivdasani RA, Bass AJ, Beroukhim R. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One 2017;12:e0176045. [PMID: 28426752 DOI: 10.1371/journal.pone.0176045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 38 |
Patel TN, Roy S, Ravi R. Gastric cancer and related epigenetic alterations. Ecancermedicalscience. 2017;11:714. [PMID: 28144288 DOI: 10.3332/ecancer.2017.714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 39 |
Zhu M, Jin G. Genetics and Molecular Signature of Gastric Cancer. Personalized Management of Gastric Cancer 2017. [DOI: 10.1007/978-981-10-3978-2_2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 40 |
Figueiredo C, Camargo MC, Leite M, Fuentes-Pananá EM, Rabkin CS, Machado JC. Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Curr Top Microbiol Immunol 2017;400:277-304. [PMID: 28124158 DOI: 10.1007/978-3-319-50520-6_12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 41 |
Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, Cheong JH, Noh SH, Kim H. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric Cancer 2016;19:1041-51. [PMID: 26573601 DOI: 10.1007/s10120-015-0565-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 42 |
Goode EF, Smyth EC. Immunotherapy for Gastroesophageal Cancer. J Clin Med. 2016;5. [PMID: 27669318 DOI: 10.3390/jcm5100084] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 43 |
Rokutan H, Hosoda F, Hama N, Nakamura H, Totoki Y, Furukawa E, Arakawa E, Ohashi S, Urushidate T, Satoh H, Shimizu H, Igarashi K, Yachida S, Katai H, Taniguchi H, Fukayama M, Shibata T. Comprehensive mutation profiling of mucinous gastric carcinoma: Somatic mutations in mucinous gastric carcinoma. J Pathol 2016;240:137-48. [DOI: 10.1002/path.4761] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 44 |
Karpińska-Kaczmarczyk K, Lewandowska M, Ławniczak M, Białek A, Urasińska E. Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland. Med Sci Monit 2016;22:2886-92. [PMID: 27527654 DOI: 10.12659/msm.897150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 46 |
Lee V, Murphy A, Le DT, Diaz LA Jr. Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. Oncologist 2016;21:1200-11. [PMID: 27412392 DOI: 10.1634/theoncologist.2016-0046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 47 |
Lee V, Murphy A, Le DT, Diaz LA Jr. Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. Oncologist. 2016;21:1200-1211. [PMID: 27412392 DOI: 10.1634/theoncologist.2016-0046] [Cited by in Crossref: 149] [Cited by in F6Publishing: 167] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 48 |
Kim HJ, Kim N, Choi YJ, Yoon H, Shin CM, Park YS, Lee HS, Ahn SH, Park do J, Kim HH, Son IT, Kang SB, Lee DH. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Gastric Cancer 2016;19:798-807. [PMID: 26445944 DOI: 10.1007/s10120-015-0552-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 49 |
Bae YS, Kim H, Noh SH. Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer. Gut Liver. 2015;9:629-635. [PMID: 26343070 DOI: 10.5009/gnl15133] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 50 |
Bockorny B, Pectasides E. The emerging role of immunotherapy in gastric and esophageal adenocarcinoma. Future Oncol. 2016;12:1833-1846. [PMID: 27166503 DOI: 10.2217/fon-2016-0103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 51 |
Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27:763-769. [PMID: 26861606 DOI: 10.1093/annonc/mdw040] [Cited by in Crossref: 115] [Cited by in F6Publishing: 129] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 52 |
El-omar EM, Mclean MH. Tumors of the Stomach. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch59] [Reference Citation Analysis]
|
| 53 |
Richman S. Deficient mismatch repair: Read all about it (Review). Int J Oncol 2015;47:1189-202. [PMID: 26315971 DOI: 10.3892/ijo.2015.3119] [Cited by in Crossref: 117] [Cited by in F6Publishing: 124] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 54 |
Farid SG, Morris-Stiff G. "OMICS" technologies and their role in foregut primary malignancies. Curr Probl Surg. 2015;52:409-441. [PMID: 26527526 DOI: 10.1067/j.cpsurg.2015.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 55 |
Bellizzi AM, Hornick JL. The stomach. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.026] [Reference Citation Analysis]
|
| 56 |
Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R. ARID1A expression in gastric adenocarcinoma: Clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol 2015; 21(7): 2159-2168 [PMID: 25717252 DOI: 10.3748/wjg.v21.i7.2159] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 57 |
Zhu L, Li Z, Wang Y, Zhang C, Liu Y, Qu X. Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis. Mol Clin Oncol. 2015;3:699-705. [PMID: 26137290 DOI: 10.3892/mco.2015.506] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 58 |
Shigeyasu K, Nagasaka T, Mori Y, Yokomichi N, Kawai T, Fuji T, Kimura K, Umeda Y, Kagawa S, Goel A, Fujiwara T. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer. PLoS One 2015;10:e0130409. [PMID: 26121593 DOI: 10.1371/journal.pone.0130409] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 59 |
Choi J, Nam SK, Park DJ, Kim HW, Kim H, Kim WH, Lee HS. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma. APMIS 2015;123:215-22. [DOI: 10.1111/apm.12345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 60 |
Hugen N, Simons M, Halilović A, van der Post RS, Bogers AJ, Marijnissen-van Zanten MA, de Wilt JH, Nagtegaal ID. The molecular background of mucinous carcinoma beyond MUC2. J Pathol Clin Res 2015;1:3-17. [PMID: 27499889 DOI: 10.1002/cjp2.1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 61 |
McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [PMID: 25134511 DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 250] [Cited by in F6Publishing: 271] [Article Influence: 27.8] [Reference Citation Analysis]
|
| 62 |
Kim HJ, Hwang SW, Kim N, Yoon H, Shin CM, Park YS, Lee DH, Park DJ, Kim HH, Kim JS, Jung HC, Lee HS. Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea. J Cancer Prev 2014;19:56-67. [PMID: 25337573 DOI: 10.15430/jcp.2014.19.1.56] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 63 |
Zhao Y, Zheng Z, Luo Y, Piao H, Zheng G, Shi J, Zhang T, Zhang J. Low-Frequency Microsatellite Instability in Genomic Di-Nucleotide Sequences Correlates with Lymphatic Invasion and Poor Prognosis in Gastric Cancer. Cell Biochem Biophys 2015;71:235-41. [DOI: 10.1007/s12013-014-0189-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 64 |
Penon D, Cito L, Giordano A. Novel findings about management of gastric cancer: A summary from 10th IGCC. World J Gastroenterol 2014; 20(27): 8986-8992 [PMID: 25083072 DOI: 10.3748/wjg.v20.i27.8986] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
|
| 65 |
Williams AS, Huang WY. The analysis of microsatellite instability in extracolonic gastrointestinal malignancy. Pathology 2013;45:540-52. [PMID: 24018804 DOI: 10.1097/PAT.0b013e3283653307] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Choi YY, Bae JM, An JY, Kwon IG, Cho I, Shin HB, Eiji T, Aburahmah M, Kim HI, Cheong JH. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol. 2014;110:129-135. [PMID: 24737677 DOI: 10.1002/jso.23618] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 67 |
Kim K, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, Kang GH. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Human Pathology 2014;45:285-93. [DOI: 10.1016/j.humpath.2013.09.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 68 |
Mao YT, Liu JL, Wang Z, Chen YY, Chen JQ. Relationship between hMLH1 methylation, microsatellite instability and gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(35): 3954-3960 [DOI: 10.11569/wcjd.v21.i35.3954] [Reference Citation Analysis]
|
| 69 |
Cho I, An JY, Kwon IG, Choi YY, Cheong JH, Hyung WJ, Noh SH. Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer. Eur J Surg Oncol 2014;40:338-44. [PMID: 24342136 DOI: 10.1016/j.ejso.2013.10.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 70 |
Kim JW, Im S, Kim MA, Cho HJ, Lee DW, Lee K, Kim T, Han S, Oh D, Lee H, Kim T, Yang H, Kim WH, Bang Y. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker: The prognostic value of ATM and MSI in gastric cancer. Int J Cancer 2014;134:72-80. [DOI: 10.1002/ijc.28245] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 71 |
Park HJ, Kim HS, Kim JW, Park SY, Kim BR, Ryu HY, Lee IY, Lee YK, Cho MY. Is microsatellite instability (MSI) associated with multiplicity in early stage gastric neoplasias? Clin Res Hepatol Gastroenterol 2013;37:400-5. [PMID: 23273496 DOI: 10.1016/j.clinre.2012.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 72 |
Tänzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013;140:133-147. [PMID: 23791941 DOI: 10.1016/j.pharmthera.2013.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 73 |
Zhang ZZ, Liu YJC, Yin XL, Zhan P, Gu Y, Ni XZ. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma. World J Gastroenterol 2013; 19(12): 1968-1974 [PMID: 23569343 DOI: 10.3748/wjg.v19.i12.1968] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 74 |
Kim JY, Shin NR, Kim A, Lee HJ, Park WY, Kim JY, Lee CH, Huh GY, Park do Y. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol. 2013;47:28-35. [PMID: 23483099 DOI: 10.4132/koreanjpathol.2013.47.1.28] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 75 |
Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation. Hum Pathol. 2013;44:1055-1064. [PMID: 23266441 DOI: 10.1016/j.humpath.2012.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 76 |
Mazzolini R, Rodrigues P, Bazzocco S, Dopeso H, Ferreira AM, Mateo-Lozano S, Andretta E, Woerner SM, Alazzouzi H, Landolfi S, Hernandez-Losa J, Macaya I, Suzuki H, Ramón y Cajal S, Mooseker MS, Mariadason JM, Gebert J, Hofstra RM, Reventós J, Yamamoto H, Schwartz S Jr, Arango D. Brush border myosin Ia inactivation in gastric but not endometrial tumors. Int J Cancer 2013;132:1790-9. [PMID: 23002058 DOI: 10.1002/ijc.27856] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 77 |
Bonnie Haferkamp, Honghong Zhang, Yuting Lin, Xinyi Yeap, Alex Bunce, Juanita Sharpe, Jialing Xiang. BaxΔ2 Is a Novel Bax Isoform Unique to Microsatellite Unstable Tumors*. J Biol Chem 2012;287. [PMID: 22910913 DOI: 10.1074/jbc.M112.374785] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 78 |
Jahng J, Youn YH, Kim KH, Yu J, Lee YC, Hyung WJ, Noh SH, Kim H, Kim H, Park H, Lee SI. Endoscopic and clinicopathologic characteristics of early gastric cancer with high microsatellite instability. World J Gastroenterol 2012; 18(27): 3571-3577 [PMID: 22826622 DOI: 10.3748/wjg.v18.i27.3571] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 79 |
Takeda Y, Yashima K, Hayashi A, Sasaki S, Kawaguchi K, Harada K, Murawaki Y, Ito H. Expression of AID, P53, and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer. World J Gastrointest Oncol 2012; 4(6): 131-137 [PMID: 22737274 DOI: 10.4251/wjgo.v4.i6.131] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 80 |
Tan IB, Ng I, Tai WM, Tan P. Understanding the genetic basis of gastric cancer: recent advances. Expert Rev Gastroenterol Hepatol 2012;6:335-41. [PMID: 22646255 DOI: 10.1586/egh.12.7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 81 |
Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol 2012;47:351-8. [PMID: 22402775 DOI: 10.1007/s00535-012-0565-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 82 |
Ottini L, Falchetti M, Nesi G. Gene Signatures in Gastric Cancer. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures 2012. [DOI: 10.1007/978-1-61779-358-5_7] [Reference Citation Analysis]
|
| 83 |
An JY, Kim H, Cheong JH, Hyung WJ, Kim H, Noh SH. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer. 2012;131:505-511. [PMID: 21898388 DOI: 10.1002/ijc.26399] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 84 |
Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22 Suppl 5:v1-v9. [PMID: 21633049 DOI: 10.1093/annonc/mdr284] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 85 |
Alves MK, Ferrasi AC, Lima VP, Ferreira MV, de Moura Campos Pardini MI, Rabenhorst SH. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. Pathobiology. 2011;78:266-276. [PMID: 21849808 DOI: 10.1159/000329475] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 86 |
Palmirotta R, Guadagni F, Savonarola A, Ludovici G, De Marchis ML, Palli D, Falchetti M, Ottini L. PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability. Clin Genet 2011;79:397-8; author reply 399-400. [PMID: 21371016 DOI: 10.1111/j.1399-0004.2010.01536.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 87 |
Palmirotta R, Guadagni F, Savonarola A, Ludovici G, Nesi G, Palli D, Falchetti M, Ottini L. PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability. Dig Liver Dis 2011;43:454-8. [PMID: 21216681 DOI: 10.1016/j.dld.2010.12.002] [Reference Citation Analysis]
|
| 88 |
Kim H, An JY, Noh SH, Shin SK, Lee YC, Kim H. High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol 2011;26:585-92. [PMID: 21332554 DOI: 10.1111/j.1440-1746.2010.06487.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 89 |
Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, Rubio CA, Mini E, Nesi G. Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol 2011; 17(3): 290-299 [PMID: 21253387 DOI: 10.3748/wjg.v17.i3.290] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 92] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 90 |
Jang B, Kim WH. Molecular Pathology of Gastric Carcinoma. Pathobiology 2011;78:302-10. [DOI: 10.1159/000321703] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 91 |
Sasaki S, Yashima K, Hayashi A, Takeda Y, Yasugi A, Koda M, Kawaguchi K, Harada K, Ito H, Murawaki Y. Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression. Oncol Lett 2011;2:217-22. [PMID: 22866067 DOI: 10.3892/ol.2010.231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 92 |
Svrcek M. [Hereditary gastric cancer: the pathologist's point of view]. Ann Pathol 2010;30:84-7. [PMID: 21055555 DOI: 10.1016/j.annpat.2010.08.005] [Reference Citation Analysis]
|
| 93 |
Song JH, Lee HS, Yoon JH, Kang YH, Nam SW, Lee JY, Park WS. TGFBR2 frameshift mutation in gastric tumors with microsatellite instability. Mol Cell Toxicol 2010;6:321-6. [DOI: 10.1007/s13273-010-0043-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 94 |
Ling ZQ, Tanaka A, Li P, Nakayama T, Fujiyama Y, Hattori T, Sugihara H. Microsatellite instability with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma. Cancer Lett. 2010;297:244-251. [PMID: 20831982 DOI: 10.1016/j.canlet.2010.05.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 95 |
Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 96 |
Choi JS, Kim MA, Lee HE, Lee HS, Kim WH. Mucinous gastric carcinomas: clinicopathologic and molecular analyses. Cancer. 2009;115:3581-3590. [PMID: 19479974 DOI: 10.1002/cncr.24422] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 97 |
Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/x00439-009-0722-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 98 |
Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/s00439-009-0722-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 99 |
Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, Ohgaki K, Morita M, Maehara Y. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol. 2009;16:2510-2515. [PMID: 19565284 DOI: 10.1245/s10434-009-0580-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 100 |
Seo HM, Chang YS, Joo SH, Kim YW, Park YK, Hong SW, Lee SH. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol. 2009;99:143-147. [PMID: 19117018 DOI: 10.1002/jso.21220] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 101 |
Carneiro F, Oliveira C, Leite M, Seruca R. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274-287. [PMID: 19013893 DOI: 10.1053/j.semdp.2008.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 102 |
D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D, Palombo F, Giuliani A, Dogliotti E. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 2009;45:461-469. [PMID: 19081245 DOI: 10.1016/j.ejca.2008.10.032] [Cited by in Crossref: 212] [Cited by in F6Publishing: 244] [Article Influence: 14.1] [Reference Citation Analysis]
|
| 103 |
Zhang HY, Li JY, Zhang JY. Effect of Fas, FasL and Caspase-3 on apoptosis of retinoic acid-induced gastric carcinoma cells. Shijie Huaren Xiaohua Zazhi 2008; 16(29): 3255-3260 [DOI: 10.11569/wcjd.v16.i29.3255] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
